Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts

Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts

10.1111/cas.14254

Saved in:

Bibliographic Details
Main Authors:	Bang, Yung-Jue, Su, Wu-Chou, Schuler, Martin, Nam, Do-Hyun, Lim, Wan Teck, Bauer, Todd M, Azaro, Analia, Poon, Ronnie Tung Ping, Hong, David, Lin, Chia-Chi, Akimov, Mikhail, Ghebremariam, Samson, Zhao, Sylvia, Giovannini, Monica, Ma, Brigette
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Language:	English
Published:	WILEY 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology capmatinib MET amplification MET dysregulation phase 1 solid tumors CELL LUNG-CANCER MOLECULE INHIBITORS BINDING C-MET PHARMACOPHORE APPROACH ACQUIRED-RESISTANCE KINASE INHIBITOR TARGETING MET AMPLIFICATION SENSITIVITY MUTATIONS
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/218537
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Be the first to leave a comment!